출판: MarketsandMarkets（마켓츠앤드마켓츠）출판년월：2021년12월
・제품(투석장치, IV장치, 환기장치, 응고 모니터, 피크 플로우 미터), 서비스(수액요법, 숙련 간호, 호스피스), 적응증(암, 상처 케어, 당뇨병), 지역별 – 2026년까지의 세계 예측
Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), & Region – Global Forecast to 2026
| 폐이지수 | 417 |
| 도표수 | 471 |
| 구성 | 영문조사보고서 |
| 가격표 |
The global home healthcare market size is projected to reach USD 298.2 billion by 2026 from USD 198.9 billion in 2021, at a CAGR of 8.4% during the forecast period. The market growth is mainly driven by factors such as the rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements in-home care devices. On the other hand, changing reimbursement policies, limited insurance coverage, and concerns regarding patient safety are factors limiting the growth of the market to a certain extent. The growing popularity of telehealth and untapped developing regions present significant growth opportunities for players in the home healthcare market.
전 세계 홈 헬스케어 시장 규모는 예측 기간 동안 8.4%의 CAGR로 2021년 1,989억 달러에서 2026년 2,982억 달러에 이를 것으로 예상됩니다.
시장 성장은 주로 노인 인구의 급속한 성장과 만성 질환의 발병률 증가, 의료 비용 증가로 인한 비용 효율적인 의료 제공의 필요성 증가, 재택 간호 장치의 기술 발전과 같은 요인에 의해 주도됩니다. 한편, 보상 정책의 변화, 제한된 보험 적용 범위, 환자 안전에 대한 우려 등은 시장 성장을 어느 정도 제한하는 요인입니다.
원격 의료 및 미개척 개발 지역의 인기가 높아짐에 따라 가정 의료 시장의 플레이어에게 상당한 성장 기회가 제공됩니다.
“The cancer segment is expected to dominate the market during the forecast period.”
Based on indication, the global home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. The cancer segment accounted for the largest share of the home healthcare market in 2020. The large share of this segment can primarily be attributed to the high prevalence of cancer cases across the globe and the transforming healthcare system, which allows the management of cancer at home.
“Testing, screening & monitoring segment will witness the highest growth in the home healthcare products market.”
Based on products, the home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. The testing, screening, and monitoring products are expected to witness the highest CAGR during the forecast period. The high growth of this segment can primarily be attributed to factors such as the rising emphasis on preventive medicine and an increasing number of patients with chronic diseases. The potential to reduce healthcare complications and ensure the portability of devices with high accuracy is also expected to create a significant demand for monitoring and testing devices in the coming year.
“North America will dominate the market during the forecast period.”
Geographically, the home healthcare market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the home healthcare market.The large share of this region in the global market is attributed to the rising prevalence of chronic conditions, high healthcare expenditure, high disposable income, the increasing overall geriatric population, high disposable income, and the presence of superior healthcare infrastructure.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type -Tier 1: 36%, Tier 2: 45%,and Tier 3: 19%
• By Designation – C-level:33%, D-level:40%, and Others:27%
• By Region – North America:36%, Europe:28%, Asia Pacific:19%, and Rest of the World: 17%
List of Companies Profiled in the Report
• Fresenius SE & Co. KGaA (Germany)
• GE Healthcare (US)
• Linde plc (Ireland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• A&D Company (Japan)
• BAYADA Home Health Care (US)
• Invacare Corporation (US)
• Abbott (US), Amedisys (US)
• ResMed (US)
• LHC Group, Inc. (US)
• OMRON Corporation (Japan)
• Koninklijke Philips N.V. (Netherlands)
• Drive DeVilbiss Healthcare (US)
• Hamilton Medical (Switzerland)
• Sunrise Medical (Germany)
• Roma Medical (UK)
• Caremax Rehabilitation Equipment Co., Ltd(China)
• Vitalograph (UK)
• advitaPflegedienst GmbH (Germany)
• RENAFAN GmbH (Germany)
• ADMR (France)
• Apex Medical Corporation (Taiwan)
• CONTEC MEDICAL SYSTEMS CO., LTD (China)
• Löwenstein Medical Technology GmbH + Co. KG. (Germany)
Research Coverage:
This report provides a detailed picture of the global home healthcare market. It aims at estimating the size and future growth potential of the market across different segments, such as product,service, indication, and region. The report also analyzes factors (such as drivers, restraints,opportunities, and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total home healthcare market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on home healthcare products and services offered by the top 25 players in the home healthcare market. The report analyses the home healthcare market by product, service, indication,and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various home healthcare across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the home healthcaremarket.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the home healthcare market.
目次
1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 49
1.3 MARKET SCOPE 50
1.3.1 MARKETS COVERED 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 51
1.4 CURRENCY 51
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 51
1.5 LIMITATIONS 52
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 53
2 RESEARCH METHODOLOGY 54
2.1 RESEARCH DATA 54
FIGURE 1 RESEARCH DESIGN 54
2.1.1 SECONDARY DATA 55
2.1.1.1 Secondary sources 56
2.1.2 PRIMARY DATA 56
2.1.2.1 Primary sources 57
2.1.2.2 Key data from primary sources 58
2.1.2.3 Key industry insights 58
2.1.2.4 Breakdown of primary interviews: By company type, designation, and region 59
2.2 MARKET SIZE ESTIMATION 59
FIGURE 2 REVENUE SHARE ANALYSIS ILLUSTRATION: F. HOFFMANN-LA ROCHE LTD. 60
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF HOME HEALTHCARE PRODUCTS AND SERVICES 60
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 61
FIGURE 5 TOP-DOWN APPROACH 62
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 63
FIGURE 6 DATA TRIANGULATION METHODOLOGY 63
2.4 MARKET SHARE ANALYSIS 63
2.5 ASSUMPTIONS FOR THE STUDY 64
2.6 LIMITATIONS 64
2.6.1 METHODOLOGY-RELATED LIMITATIONS 64
2.7 RISK ASSESSMENT 65
TABLE 2 RISK ASSESSMENT: HOME HEALTHCARE MARKET 65
2.8 COVID-19 HEALTH ASSESSMENT 65
2.9 COVID-19 ECONOMIC ASSESSMENT 65
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 66
FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY 66
3 EXECUTIVE SUMMARY 68
FIGURE 9 HOME HEALTHCARE MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION) 68
FIGURE 10 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD BILLION) 69
FIGURE 11 HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD BILLION) 69
FIGURE 12 HOME HEALTHCARE MARKET, BY INDICATION, 2021 VS. 2026 (USD BILLION) 70
FIGURE 13 HOME HEALTHCARE MARKET, BY REGION, 2021 VS. 2026 (USD BILLION) 70
4 PREMIUM INSIGHTS 72
4.1 HOME HEALTHCARE MARKET OVERVIEW 72
FIGURE 14 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 72
4.2 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 73
FIGURE 15 INHALERS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 73
4.3 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY MOBILITY CARE PRODUCT AND COUNTRY (2020) 74
FIGURE 16 WHEELCHAIRS DOMINATED THE ASIA PACIFIC HOME HEALTHCARE MARKET IN 2020 74
4.4 HOME HEALTHCARE MARKET, BY SERVICE, 2021–2026 75
FIGURE 17 INFUSION THERAPY SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026) 75
4.5 HOME HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 75
FIGURE 18 JAPAN IS THE FASTEST-GROWING MARKET FOR HOME HEALTHCARE 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 76
FIGURE 19 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 76
5.2.1 DRIVERS 77
5.2.1.1 Rapid growth in the elderly population and the rising incidence of chronic diseases 77
TABLE 3 OVERVIEW OF THE GERIATRIC POPULATION (MILLION) 77
FIGURE 20 GERIATRIC POPULATION, BY COUNTRY, 2010 VS. 2019 (% OF THE TOTAL POPULATION) 77
5.2.1.2 Rising R&D investments resulting in technologically advanced devices 78
TABLE 4 PRODUCT LAUNCHES 79
FIGURE 21 R&D EXPENDITURE (% OF TOTAL REVENUE), BY KEY PLAYER, 2019. VS 2020 79
5.2.1.3 Growing need for cost-effective healthcare delivery due to the increasing healthcare costs 80
5.2.1.4 Outbreak of the COVID-19 pandemic 80
5.2.2 RESTRAINTS 81
5.2.2.1 Changing reimbursement policies 81
5.2.2.2 Limited insurance coverage 82
5.2.2.3 Patient safety concerns 82
5.2.3 OPPORTUNITIES 82
5.2.3.1 Rising focus on telehealth 82
5.2.3.2 Untapped developing regions 83
5.2.3.3 Growing demand for home care therapeutic devices 83
5.2.3.4 Growing demand for home sleep apnea tests (HSATs) 84
5.2.3.5 Growing preference for home hemodialysis treatment 85
5.2.4 CHALLENGES 86
5.2.4.1 Shortage of homecare workers 86
5.3 RANGES/SCENARIOS 86
5.3.1 HOME HEALTHCARE MARKET 86
FIGURE 22 PESSIMISTIC SCENARIO 86
FIGURE 23 OPTIMISTIC SCENARIO 87
FIGURE 24 REALISTIC SCENARIO 87
5.4 REGULATORY ANALYSIS 88
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES 88
5.4.1 NORTH AMERICA 88
5.4.1.1 US 88
TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA 89
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 89
FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 90
5.4.1.2 Canada 90
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
FIGURE 26 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA 91
5.4.2 EUROPE 91
FIGURE 27 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES 92
5.4.3 ASIA PACIFIC 92
5.4.3.1 Japan 92
TABLE 9 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN 92
5.4.3.2 China 93
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES 93
5.4.3.3 India 94
5.5 PORTER’S FIVE FORCES ANALYSIS: PULSE OXIMETERS MARKET 95
TABLE 11 PORTER’S FIVE FORCES ANALYSIS FOR THE PULSE OXIMETERS MARKET 95
5.5.1 THREAT OF NEW ENTRANTS 95
5.5.2 THREAT OF SUBSTITUTES 96
5.5.3 BARGAINING POWER OF SUPPLIERS 96
5.5.4 BARGAINING POWER OF BUYERS 96
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.6 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET 97
TABLE 12 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET 97
5.6.1 THREAT OF NEW ENTRANTS 97
5.6.2 THREAT OF SUBSTITUTES 97
5.6.3 BARGAINING POWER OF BUYERS 97
5.6.4 BARGAINING POWER OF SUPPLIERS 97
5.6.5 DEGREE OF COMPETITION 98
5.7 TECHNOLOGY ANALYSIS 98
5.8 VALUE CHAIN ANALYSIS 99
FIGURE 28 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE 99
5.9 SUPPLY CHAIN ANALYSIS 100
FIGURE 29 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 101
5.10 PATENT ANALYSIS 101
5.10.1 PATENT GRANTED TRENDS FOR HOME HEALTHCARE 101
FIGURE 30 PATENT GRANTED TRENDS, JANUARY 2011–NOVEMBER 2021 102
5.10.2 JURISDICTION AND TOP APPLICANT ANALYSIS 102
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PULSE OXIMETER PATENTS, JANUARY 2011—NOVEMBER 2021 103
5.11 TRADE ANALYSIS 103
TABLE 13 IMPORT DATA FOR HS CODE 901890 – INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD MILLION) 104
TABLE 14 EXPORT DATA FOR HS CODE 901890 – INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD MILLION) 104
5.12 PRICING ANALYSIS 105
TABLE 15 PRICE RANGE FOR HOME CARE DEVICES, BY COUNTRY 105
TABLE 16 PRICES OF HEARING AIDS (2021) 109
5.13 ECOSYSTEM ANALYSIS 110
FIGURE 32 HOME HEALTHCARE DEVICES MARKET: ECOSYSTEM ANALYSIS 110
5.13.1 ROLE IN THE ECOSYSTEM 111
FIGURE 33 KEY PLAYERS IN THE HOME HEALTHCARE ECOSYSTEM 111
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 112
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR HOME HEALTHCARE PRODUCT MANUFACTURERS OR SERVICE PROVIDERS 112
FIGURE 34 REVENUE SHIFT FOR HOME HEALTHCARE PRODUCTS AND SERVICES 112
TABLE 17 ADJACENT MARKETS AND THEIR CURRENT GROWTH 112
6 HOME HEALTHCARE MARKET, BY PRODUCT 113
6.1 INTRODUCTION 114
TABLE 18 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD BILLION) 114
TABLE 19 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD BILLION) 114
TABLE 20 HOME HEALTHCARE PRODUCTS MARKET, BY REGION,
2018–2020 (USD BILLION) 115
TABLE 21 HOME HEALTHCARE PRODUCTS MARKET, BY REGION,
2021–2026 (USD BILLION) 115
6.2 THERAPEUTIC PRODUCTS 115
TABLE 22 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 116
TABLE 23 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 116
TABLE 24 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION,
2018–2020 (USD BILLION) 117
TABLE 25 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION,
2021–2026 (USD BILLION) 117
6.2.1 DIALYSIS EQUIPMENT 117
6.2.1.1 Dialysis equipment has gained significance due to its improved clinical outcomes and better quality of life for patients 117
TABLE 26 DIALYSIS EQUIPMENT MARKET, BY REGION, 2018–2020 (USD MILLION) 118
TABLE 27 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021–2026 (USD MILLION) 119
6.2.2 WOUND CARE PRODUCTS 119
6.2.2.1 Decreased cost and higher convenience and comfort of home care will ensure the growth of this segment 119
TABLE 28 WOUND CARE PRODUCTS MARKET, BY REGION, 2018–2020 (USD MILLION) 120
TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION) 120
6.2.3 IV EQUIPMENT 120
6.2.3.1 IV equipment facilitates the delivery of antibiotics, fluid replacements, and chemotherapy with accuracy 120
TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2018–2020 (USD MILLION) 121
TABLE 31 IV EQUIPMENT MARKET, BY REGION, 2021–2026 (USD MILLION) 121
6.2.4 SLEEP APNEA THERAPEUTIC DEVICES 122
6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market growth 122
TABLE 32 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 123
TABLE 33 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 123
6.2.5 INSULIN DELIVERY DEVICES 123
6.2.5.1 High incidence of diabetes to drive the insulin delivery devices market 123
TABLE 34 INSULIN DELIVERY DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 124
TABLE 35 INSULIN DELIVERY DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 124
6.2.6 OXYGEN DELIVERY SYSTEMS 124
6.2.6.1 Technological advancements in oxygen therapy products to drive the market 124
TABLE 36 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION,
2018–2020 (USD MILLION) 125
TABLE 37 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION) 125
6.2.7 INHALERS 126
6.2.7.1 High incidence of asthma is the major factor driving market growth 126
TABLE 38 INHALERS MARKET, BY REGION, 2018–2020 (USD MILLION) 126
TABLE 39 INHALERS MARKET, BY REGION, 2021–2026 (USD MILLION) 127
6.2.8 NEBULIZERS 127
6.2.8.1 Nebulizers are more effective as compared to oral dosages 127
TABLE 40 NEBULIZERS AVAILABLE IN THE MARKET 127
TABLE 41 NEBULIZERS MARKET, BY REGION, 2018–2020 (USD MILLION) 129
TABLE 42 NEBULIZERS MARKET, BY REGION, 2021–2026 (USD MILLION) 129
6.2.9 VENTILATORS 129
6.2.9.1 Home care ventilators are convenient and can be used in the comfort of the patient’s home 129
TABLE 43 VENTILATORS MARKET, BY REGION, 2018–2020 (USD MILLION) 130
TABLE 44 VENTILATORS MARKET, BY REGION, 2021–2026 (USD MILLION) 130
6.2.10 OTHER THERAPEUTIC PRODUCTS 131
TABLE 45 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION,
2018–2020 (USD MILLION) 131
TABLE 46 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION,
2021–2026 (USD MILLION) 132
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS 132
TABLE 47 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 133
TABLE 48 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 134
TABLE 49 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2018–2020 (USD BILLION) 135
TABLE 50 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2021–2026 (USD BILLION) 135
6.3.1 BLOOD GLUCOSE MONITORS 135
6.3.1.1 Increasing prevalence of diabetes to drive the market growth 135
TABLE 51 BLOOD GLUCOSE MONITORS MARKET, BY REGION,
2018–2020 (USD MILLION) 136
TABLE 52 BLOOD GLUCOSE MONITORS MARKET, BY REGION,
2021–2026 (USD MILLION) 137
6.3.2 HEARING AIDS 137
6.3.2.1 High incidence of hearing impairment to drive the market 137
TABLE 53 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020,
BY AGE GROUP 138
TABLE 54 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP (10-YEAR RANGE) 138
TABLE 55 GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP 139
TABLE 56 HEARING AIDS MARKET, BY REGION, 2018–2020 (USD MILLION) 139
TABLE 57 HEARING AIDS MARKET, BY REGION, 2021–2026 (USD MILLION) 139
6.3.3 BLOOD PRESSURE MONITORS 140
6.3.3.1 Increasing number of patients with hypertension and amplified occurrence of cardiovascular diseases to drive the market growth 140
TABLE 58 BLOOD PRESSURE MONITORS MARKET, BY REGION,
2018–2020 (USD MILLION) 141
TABLE 59 BLOOD PRESSURE MONITORS MARKET, BY REGION,
2021–2026 (USD MILLION) 141
6.3.4 ECG/EKG DEVICES 141
6.3.4.1 High prevalence of cardiovascular diseases to drive the market 141
TABLE 60 ECG/EKG DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION) 142
TABLE 61 ECG/EKG DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 143
6.3.5 OVULATION & PREGNANCY TEST KITS 143
6.3.5.1 Privacy, convenience, accessibility, and quick results to drive the market for ovulation and pregnancy test kits 143
TABLE 62 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION,
2018–2020 (USD MILLION) 143
TABLE 63 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION,
2021–2026 (USD MILLION) 144
6.3.6 PULSE OXIMETERS 144
6.3.6.1 Pulse oximeters are used to measure oxygen saturation in the blood 144
TABLE 64 PULSE OXIMETERS OFFERED BY MAJOR PLAYERS 145
TABLE 65 PULSE OXIMETERS MARKET, BY REGION, 2018–2020 (USD MILLION) 145
TABLE 66 PULSE OXIMETERS MARKET, BY REGION, 2021–2026 (USD MILLION ) 145
6.3.7 HEART RATE MONITORS 146
6.3.7.1 Ability to continuously monitor critical cardiac parameters to drive the demand for heart rate monitors 146
TABLE 67 HEART RATE MONITORS MARKET, BY REGION, 2018–2020 (USD MILLION) 146
TABLE 68 HEART RATE MONITORS MARKET, BY REGION, 2021–2026 (USD MILLION) 146
6.3.8 COAGULATION MONITORING PRODUCTS 147
6.3.8.1 Coagulation monitors are used for routine management of prothrombin time/international normalized ratio for safe and effective management 147
TABLE 69 COAGULATION MONITORING PRODUCTS MARKET, BY REGION,
2018–2020 (USD MILLION) 147
TABLE 70 COAGULATION MONITORING PRODUCTS MARKET, BY REGION,
2021–2026 (USD MILLION) 148
6.3.9 FETAL MONITORING DEVICES 148
6.3.9.1 Remote-based care by portable fetal monitoring systems to drive market growth 148
TABLE 71 FETAL MONITORING DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 149
TABLE 72 FETAL MONITORING DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 150
6.3.10 HIV TEST KITS 150
6.3.10.1 Rising prevalence of HIV to drive the market 150
TABLE 73 HIV TEST KITS MARKET, BY REGION, 2018–2020 (USD MILLION) 150
TABLE 74 HIV TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION) 151
6.3.11 HOLTER & EVENT MONITORS 151
6.3.11.1 Rising awareness of preventive care and technological advancements to drive the market 151
TABLE 75 HOLTER & EVENT MONITORS MARKET, BY REGION,
2018–2020 (USD MILLION) 151
TABLE 76 HOLTER & EVENT MONITORS MARKET, BY REGION,
2021–2026 (USD MILLION) 152
6.3.12 TEMPERATURE MONITORING DEVICES 152
6.3.12.1 Technological innovations and increasing awareness on the use of temperature monitoring devices for personal care to drive market growth 152
TABLE 77 TEMPERATURE MONITORING DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 152
TABLE 78 TEMPERATURE MONITORING DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 153
6.3.13 CHOLESTEROL TESTING PRODUCTS 153
6.3.13.1 Rising obesity levels and the incidence of cardiovascular disorders are supporting market growth 153
TABLE 79 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 154
TABLE 80 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 154
6.3.14 DRUG & ALCOHOL TEST KITS 154
6.3.14.1 Rising consumption of drugs among teens to support market growth 154
TABLE 81 RECENT APPROVALS FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES 155
TABLE 82 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION,
2018–2020 (USD MILLION) 155
TABLE 83 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION,
2021–2026 (USD MILLION) 156
6.3.15 PEAK FLOW METERS 156
6.3.15.1 Peak flow meters are used to monitor a person’s ability to breathe 156
TABLE 84 PEAK FLOW METERS MARKET, BY REGION, 2018–2020 (USD MILLION) 156
TABLE 85 PEAK FLOW METERS MARKET, BY REGION, 2021–2026 (USD MILLION) 157
6.3.16 COLON CANCER TEST KITS 157
6.3.16.1 High incidence of colorectal cancer to drive the market growth 157
TABLE 86 COLON CANCER TEST KITS MARKET, BY REGION, 2018–2020 (USD MILLION) 157
TABLE 87 COLON CANCER TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION) 158
6.3.17 ACTIVITY MONITORS & WRIST BANDS 158
6.3.17.1 Increasing prevalence of chronic diseases has resulted in a significant increase in the demand for activity monitors 158
TABLE 88 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION,
2018–2020 (USD MILLION) 158
TABLE 89 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION,
2021–2026 (USD MILLION) 159
6.3.18 EEG DEVICES 159
6.3.18.1 Emergence of epilepsy as a common neurological condition to drive the market for EEG devices 159
TABLE 90 EEG DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION) 160
TABLE 91 EEG DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 160
6.3.19 HOME SLEEP TESTING DEVICES 160
6.3.19.1 Cost-effectiveness of home-based sleep tests to fuel the growth of home sleep testing devices 160
TABLE 92 HOME SLEEP TESTING DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 161
TABLE 93 HOME SLEEP TESTING DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 162
6.3.20 HOME HEMOGLOBIN A1C TEST KITS 162
6.3.20.1 High incidence of diabetes to drive market growth 162
TABLE 94 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION,
2018–2020 (USD MILLION) 162
TABLE 95 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION,
2021–2026 (USD MILLION) 163
6.4 MOBILITY CARE PRODUCTS 163
TABLE 96 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 163
TABLE 97 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 164
TABLE 98 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY REGION, 2018–2020 (USD MILLION) 164
TABLE 99 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION) 164
6.4.1 WHEELCHAIRS 165
6.4.1.1 Increased preference for wheelchairs to support market growth 165
TABLE 100 WHEELCHAIRS MARKET, BY REGION, 2018–2020 (USD MILLION) 165
TABLE 101 WHEELCHAIRS MARKET, BY REGION, 2021–2026 (USD MILLION) 166
6.4.2 MOBILITY SCOOTERS 166
6.4.2.1 Mobility scooters help users to travel long distances 166
TABLE 102 MOBILITY SCOOTERS MARKET, BY REGION, 2018–2020 (USD MILLION) 166
TABLE 103 MOBILITY SCOOTERS MARKET, BY REGION, 2021–2026 (USD MILLION) 167
6.4.3 WALKERS & ROLLATORS 167
6.4.3.1 Walkers are used by the disabled and the elderly for additional support while walking 167
TABLE 104 WALKERS AND ROLLATORS MARKET, BY REGION,
2018–2020 (USD MILLION) 167
TABLE 105 WALKERS AND ROLLATORS MARKET, BY REGION,
2021–2026 (USD MILLION) 168
6.4.4 CRUTCHES 168
6.4.4.1 Axilla crutches are the most preferred as they are easy to use and are often used by people who have a temporary injury 168
TABLE 106 CRUTCHES MARKET, BY REGION, 2018–2020 (USD MILLION) 168
TABLE 107 CRUTCHES MARKET, BY REGION, 2021–2026 (USD MILLION) 169
6.4.5 CANES 169
6.4.5.1 Canes are the most common assistive devices 169
TABLE 108 CANES MARKET, BY REGION, 2018–2020 (USD MILLION) 169
TABLE 109 CANES MARKET, BY REGION, 2021–2026 (USD MILLION) 170
7 HOME HEALTHCARE MARKET, BY SERVICE 171
7.1 INTRODUCTION 172
TABLE 110 US: AVERAGE SENIOR CARE COST, BY TYPE AND DURATION, 2019 172
TABLE 111 HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD BILLION) 173
TABLE 112 HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD BILLION) 173
TABLE 113 HOME HEALTHCARE SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 174
TABLE 114 HOME HEALTHCARE SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 174
7.2 SKILLED NURSING 174
7.2.1 SKILLED NURSING SERVICES TO DOMINATE THE HOME HEALTHCARE SERVICES MARKET DURING THE FORECAST PERIOD 174
TABLE 115 SKILLED NURSING SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 175
TABLE 116 SKILLED NURSING SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 175
7.3 REHABILITATION THERAPY 175
7.3.1 REHABILITATION THERAPY SERVICES MAJORLY INCLUDE PHYSIOTHERAPY, OCCUPATIONAL THERAPY, AND SPEECH THERAPY 175
TABLE 117 REHABILITATION THERAPY SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 176
TABLE 118 REHABILITATION THERAPY SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 176
7.4 HOSPICE & PALLIATIVE CARE 177
7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE & PALLIATIVE CARE SERVICES 177
TABLE 119 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 177
TABLE 120 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 178
7.5 UNSKILLED CARE 178
7.5.1 UNSKILLED CARE SERVICES ARE COST-EFFECTIVE AND OFFER COMFORT AND SECURITY TO PATIENTS 178
TABLE 121 UNSKILLED CARE SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 179
TABLE 122 UNSKILLED CARE SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 179
7.6 RESPIRATORY THERAPY 179
7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET GROWTH 179
TABLE 123 RESPIRATORY THERAPY SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 180
TABLE 124 RESPIRATORY THERAPY SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 180
7.7 INFUSION THERAPY 181
7.7.1 HOME INFUSION IS A SAFE AND EFFECTIVE ALTERNATIVE TO IN-PATIENT CARE FOR VARIOUS DISEASE STATES AND THERAPIES 181
TABLE 125 INFUSION THERAPY SERVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 182
TABLE 126 INFUSION THERAPY SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 182
7.8 PREGNANCY CARE 182
7.8.1 PREGNANCY CARE SERVICES HELP EXPECTANT PARENTS TO MANAGE HIGH-RISK PREGNANCIES AND COMPLICATIONS 182
TABLE 127 PREGNANCY CARE SERVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 183
TABLE 128 PREGNANCY CARE SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 184
8 HOME HEALTHCARE MARKET, BY INDICATION 185
8.1 INTRODUCTION 186
TABLE 129 HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD BILLION) 186
TABLE 130 HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD BILLION) 186
8.2 CANCER 187
8.2.1 HIGH PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 187
TABLE 131 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION) 187
TABLE 132 PROJECTED INCREASE IN THE GLOBAL NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2035 188
TABLE 133 HOME HEALTHCARE MARKET FOR CANCER, BY REGION,
2018–2020 (USD BILLION) 188
TABLE 134 HOME HEALTHCARE MARKET FOR CANCER, BY REGION,
2021–2026 (USD BILLION) 189
8.3 RESPIRATORY DISEASES 189
8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES IS A KEY FACTOR DRIVING MARKET GROWTH 189
TABLE 135 INCIDENCE OF TB, 2019 190
TABLE 136 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2020 (USD BILLION) 190
TABLE 137 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2021–2026 (USD BILLION) 191
8.4 MOVEMENT DISORDERS 191
8.4.1 AGING IS A RISK FACTOR FOR MOVEMENT DISORDERS 191
TABLE 138 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2018–2020 (USD BILLION) 191
TABLE 139 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2021–2026 (USD BILLION) 192
8.5 CARDIOVASCULAR DISEASES & HYPERTENSION 192
8.5.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT 192
TABLE 140 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION, BY REGION, 2018–2020 (USD BILLION) 193
TABLE 141 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION, BY REGION, 2021–2026 (USD BILLION) 193
8.6 PREGNANCY 193
8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH 193
TABLE 142 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION,
2018–2020 (USD BILLION) 194
TABLE 143 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION,
2021–2026 (USD BILLION) 194
8.7 WOUND CARE 195
8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET GROWTH 195
TABLE 144 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION,
2018–2020 (USD BILLION) 195
TABLE 145 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION,
2021–2026 (USD BILLION) 196
8.8 DIABETES 196
8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH 196
TABLE 146 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION,
2018–2020 (USD BILLION) 197
TABLE 147 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION,
2021–2026 (USD BILLION) 197
8.9 HEARING DISORDERS 197
8.9.1 PREVALENCE OF HEARING LOSS IS HIGHER IN THE AGING POPULATION 197
TABLE 148 GLOBAL INCIDENCE OF HEARING DISORDERS 198
TABLE 149 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2018–2020 (USD BILLION) 198
TABLE 150 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2021–2026 (USD BILLION) 198
8.10 OTHER INDICATIONS 199
TABLE 151 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,
2018–2020 (USD BILLION) 199
TABLE 152 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,
2021–2026 (USD BILLION) 200
9 HOME HEALTHCARE MARKET, BY REGION 201
9.1 INTRODUCTION 202
TABLE 153 HOME HEALTHCARE MARKET, BY REGION, 2018–2020 (USD BILLION) 202
TABLE 154 HOME HEALTHCARE MARKET, BY REGION, 2021–2026 (USD BILLION) 202
9.2 NORTH AMERICA 203
FIGURE 35 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT 203
TABLE 155 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY,
2018–2020 (USD BILLION) 204
TABLE 156 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY,
2021–2026 (USD BILLION) 204
TABLE 157 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE,
2018–2020 (USD BILLION) 204
TABLE 158 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE,
2021–2026 (USD BILLION) 204
TABLE 159 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 205
TABLE 160 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 205
TABLE 161 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 206
TABLE 162 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 207
TABLE 163 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 208
TABLE 164 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 208
TABLE 165 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 209
TABLE 166 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 209
TABLE 167 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 210
TABLE 168 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 210
TABLE 169 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 211
TABLE 170 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 211
9.2.1 US 212
9.2.1.1 The US dominates the North American home healthcare market 212
TABLE 171 US: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD BILLION) 213
TABLE 172 US: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD BILLION) 213
TABLE 173 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 214
TABLE 174 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 214
TABLE 175 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 215
TABLE 176 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 216
TABLE 177 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 217
TABLE 178 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 217
TABLE 179 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 218
TABLE 180 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 218
TABLE 181 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 219
TABLE 182 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 219
TABLE 183 US: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 220
TABLE 184 US: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 220
9.2.2 CANADA 221
9.2.2.1 Rising geriatric population in the country to drive market growth 221
TABLE 185 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 222
TABLE 186 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 222
TABLE 187 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 223
TABLE 188 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 223
TABLE 189 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 224
TABLE 190 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 225
TABLE 191 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 226
TABLE 192 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 226
TABLE 193 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 227
TABLE 194 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 227
TABLE 195 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 228
TABLE 196 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 228
TABLE 197 CANADA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 229
TABLE 198 CANADA: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 229
9.3 EUROPE 230
TABLE 199 EUROPE: PERCENTAGE OF POPULATION AGED 60 AND OVER, 2017 VS. 2050 230
TABLE 200 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION,
2018–2020 (USD BILLION) 231
TABLE 201 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION,
2021–2026 (USD BILLION) 231
TABLE 202 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 231
TABLE 203 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 232
TABLE 204 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 232
TABLE 205 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 232
TABLE 206 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 233
TABLE 207 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 234
TABLE 208 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 235
TABLE 209 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 235
TABLE 210 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 236
TABLE 211 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 236
TABLE 212 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 237
TABLE 213 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 237
TABLE 214 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 238
TABLE 215 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 238
9.3.1 GERMANY 239
9.3.1.1 Germany to dominate the European home healthcare market 239
TABLE 216 GERMANY: KEY MACROINDICATORS 240
TABLE 217 GERMANY: HOME HEALTHCARE MARKET, BY TYPE,
2018–2020 (USD MILLION) 240
TABLE 218 GERMANY: HOME HEALTHCARE MARKET, BY TYPE,
2021–2026 (USD MILLION) 240
TABLE 219 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 241
TABLE 220 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 241
TABLE 221 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 242
TABLE 222 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 243
TABLE 223 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 244
TABLE 224 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 244
TABLE 225 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 245
TABLE 226 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 245
TABLE 227 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 246
TABLE 228 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 246
TABLE 229 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 247
TABLE 230 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 247
9.3.2 FRANCE 248
9.3.2.1 Government support and initiatives taken by market players to drive the home healthcare market 248
TABLE 231 FRANCE: KEY INDICATORS 248
TABLE 232 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 249
TABLE 233 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 249
TABLE 234 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 249
TABLE 235 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 250
TABLE 236 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 250
TABLE 237 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 251
TABLE 238 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 252
TABLE 239 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 252
TABLE 240 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 253
TABLE 241 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 253
TABLE 242 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 254
TABLE 243 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 254
TABLE 244 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 255
TABLE 245 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 255
9.3.3 UK 256
9.3.3.1 High burden of chronic diseases to drive the market in the country 256
TABLE 246 UK: KEY MACROINDICATORS 256
TABLE 247 UK: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 257
TABLE 248 UK: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 257
TABLE 249 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 257
TABLE 250 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 258
TABLE 251 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 258
TABLE 252 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 259
TABLE 253 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 260
TABLE 254 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 260
TABLE 255 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 261
TABLE 256 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 261
TABLE 257 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 262
TABLE 258 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 262
TABLE 259 UK: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 263
TABLE 260 UK: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 263
9.3.4 ITALY 264
9.3.4.1 Rising geriatric population and the favorable government policy to drive the market in the country 264
TABLE 261 ITALY: KEY INDICATORS 264
TABLE 262 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 264
TABLE 263 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 265
TABLE 264 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 265
TABLE 265 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 265
TABLE 266 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 266
TABLE 267 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 267
TABLE 268 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 268
TABLE 269 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 268
TABLE 270 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 269
TABLE 271 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 269
TABLE 272 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 270
TABLE 273 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 270
TABLE 274 ITALY: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 271
TABLE 275 ITALY: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 271
9.3.5 SPAIN 272
9.3.5.1 Rising geriatric population and the increasing incidence of chronic conditions to drive market growth 272
TABLE 276 SPAIN: KEY INDICATORS 272
TABLE 277 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 273
TABLE 278 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 273
TABLE 279 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 273
TABLE 280 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 274
TABLE 281 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 274
TABLE 282 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 275
TABLE 283 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 276
TABLE 284 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 276
TABLE 285 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 277
TABLE 286 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 277
TABLE 287 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 278
TABLE 288 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 278
TABLE 289 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 279
TABLE 290 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 279
9.3.6 REST OF EUROPE 280
TABLE 291 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP) 280
TABLE 292 ROE: PERCENTAGE OF POPULATION AGED 60 AND OVER, 2017 VS. 2050 281
TABLE 293 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 281
TABLE 294 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 281
TABLE 295 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 282
TABLE 296 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 282
TABLE 297 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 283
TABLE 298 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 284
TABLE 299 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 285
TABLE 300 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 285
TABLE 301 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 286
TABLE 302 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 286
TABLE 303 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 287
TABLE 304 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 287
TABLE 305 ROE: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 288
TABLE 306 ROE: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 288
9.4 ASIA PACIFIC 289
FIGURE 36 ASIA PACIFIC: HOME HEALTHCARE MARKET SNAPSHOT 289
TABLE 307 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY,
2018–2020 (USD BILLION) 290
TABLE 308 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY,
2021–2026 (USD BILLION) 290
TABLE 309 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE,
2018–2020 (USD MILLION) 290
TABLE 310 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE,
2021–2026 (USD MILLION) 291
TABLE 311 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 291
TABLE 312 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 291
TABLE 313 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 292
TABLE 314 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 293
TABLE 315 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 294
TABLE 316 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 294
TABLE 317 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 295
TABLE 318 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 295
TABLE 319 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 296
TABLE 320 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 296
TABLE 321 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 297
TABLE 322 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 297
9.4.1 JAPAN 298
9.4.1.1 Growing geriatric population in the country to drive the home healthcare market 298
TABLE 323 JAPAN: KEY INDICATORS 298
TABLE 324 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 299
TABLE 325 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 299
TABLE 326 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 299
TABLE 327 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 300
TABLE 328 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 300
TABLE 329 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 301
TABLE 330 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 302
TABLE 331 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 302
TABLE 332 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 303
TABLE 333 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 303
TABLE 334 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 304
TABLE 335 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 304
TABLE 336 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 305
TABLE 337 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 305
9.4.2 CHINA 306
9.4.2.1 Healthcare development and reforms will drive the market in the country 306
TABLE 338 CHINA: KEY INDICATORS 306
TABLE 339 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 306
TABLE 340 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 307
TABLE 341 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 307
TABLE 342 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 307
TABLE 343 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 308
TABLE 344 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 309
TABLE 345 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 310
TABLE 346 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 310
TABLE 347 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 311
TABLE 348 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 311
TABLE 349 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 312
TABLE 350 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 312
TABLE 351 CHINA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 313
TABLE 352 CHINA: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 313
9.4.3 INDIA 314
9.4.3.1 Increasing target patient population to drive the market in the country 314
TABLE 353 INDIA: KEY INDICATORS 315
TABLE 354 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 315
TABLE 355 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 315
TABLE 356 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 316
TABLE 357 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 316
TABLE 358 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 317
TABLE 359 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 318
TABLE 360 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 319
TABLE 361 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 319
TABLE 362 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 320
TABLE 363 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 320
TABLE 364 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 321
TABLE 365 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 321
TABLE 366 INDIA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 322
TABLE 367 INDIA: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 322
9.4.4 REST OF ASIA PACIFIC 323
TABLE 368 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 323
TABLE 369 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 323
TABLE 370 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 324
TABLE 371 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 324
TABLE 372 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 325
TABLE 373 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 326
TABLE 374 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 327
TABLE 375 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 327
TABLE 376 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 328
TABLE 377 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 328
TABLE 378 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 329
TABLE 379 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 329
TABLE 380 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 330
TABLE 381 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 330
9.5 REST OF THE WORLD 331
TABLE 382 MEXICO: KEY INDICATORS 331
TABLE 383 BRAZIL: KEY INDICATORS 331
TABLE 384 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 332
TABLE 385 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 332
TABLE 386 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 332
TABLE 387 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 333
TABLE 388 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 333
TABLE 389 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 334
TABLE 390 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 335
TABLE 391 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 335
TABLE 392 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 336
TABLE 393 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 336
TABLE 394 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 337
TABLE 395 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 337
TABLE 396 ROW: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 338
TABLE 397 ROW: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 338
10 COMPETITIVE LANDSCAPE 339
10.1 OVERVIEW 339
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 339
TABLE 398 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE HOME HEALTHCARE MARKET 339
10.3 MARKET SHARE ANALYSIS, 2020 342
FIGURE 37 SLEEP APNEA DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 343
FIGURE 38 HEARING AIDS MARKET SHARE, BY KEY PLAYER, 2020 345
10.4 COMPETITIVE LEADERSHIP MAPPING 349
10.4.1 STARS 349
10.4.2 EMERGING LEADERS 349
10.4.3 PERVASIVE PLAYERS 349
10.4.4 PARTICIPANTS 349
FIGURE 39 HOME HEALTHCARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 350
10.5 COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS 350
10.5.1 PROGRESSIVE COMPANIES 350
10.5.2 STARTING BLOCKS 351
10.5.3 RESPONSIVE COMPANIES 351
10.5.4 DYNAMIC COMPANIES 351
FIGURE 40 HOME HEALTHCARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS (2020) 351
10.6 COMPANY FOOTPRINT 352
TABLE 399 COMPANY FOOTPRINT 352
TABLE 400 COMPANY PRODUCT FOOTPRINT 353
TABLE 401 COMPANY REGIONAL FOOTPRINT 354
10.7 COMPETITIVE SCENARIO 355
10.7.1 PRODUCT LAUNCHES & APPROVALS 355
TABLE 402 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018–OCTOBER 2021 355
10.7.2 DEALS 356
TABLE 403 KEY DEALS, JANUARY 2018–OCTOBER 2021 356
10.7.3 OTHER DEVELOPMENTS 358
TABLE 404 OTHER KEY DEVELOPMENTS, JANUARY 2018–OCTOBER 2021 358
11 COMPANY PROFILES 359
11.1 KEY PLAYERS 359
(Business overview, Products offered, Recent developments, MnM view, Key strengths/right to win, Strategic choices made, and Weaknesses and competitive threats)*
11.1.1 FRESENIUS SE & CO. KGAA 359
TABLE 405 FRESENIUS SE & CO. KGAA: BUSINESS OVERVIEW 359
FIGURE 41 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2020) 360
11.1.2 LINDE PLC 364
TABLE 406 LINDE PLC: BUSINESS OVERVIEW 364
FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2020) 365
11.1.3 F. HOFFMANN-LA ROCHE LTD. 367
TABLE 407 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 367
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020) 368
11.1.4 A&D COMPANY, LIMITED 370
TABLE 408 A&D COMPANY, LIMITED: BUSINESS OVERVIEW 370
FIGURE 44 A&D COMPANY, LIMITED: COMPANY SNAPSHOT (2020) 371
11.1.5 BAYADA HOME HEALTH CARE 373
TABLE 409 BAYADA HOME HEALTH CARE: BUSINESS OVERVIEW 373
11.1.6 INVACARE CORPORATION 377
TABLE 410 INVACARE CORPORATION: BUSINESS OVERVIEW 377
FIGURE 45 INVACARE CORPORATION: COMPANY SNAPSHOT (2020) 378
11.1.7 ABBOTT 381
TABLE 411 ABBOTT: BUSINESS OVERVIEW 381
FIGURE 46 ABBOTT: COMPANY SNAPSHOT (2020) 382
11.1.8 AMEDISYS 385
TABLE 412 AMEDISYS: BUSINESS OVERVIEW 385
FIGURE 47 AMEDISYS: COMPANY SNAPSHOT (2020) 385
11.1.9 RESMED 389
TABLE 413 RESMED: BUSINESS OVERVIEW 389
FIGURE 48 RESMED: COMPANY SNAPSHOT (2020) 390
11.1.10 LHC GROUP, INC. 395
TABLE 414 LHC GROUP, INC.: BUSINESS OVERVIEW 395
FIGURE 49 LHC GROUP, INC.: COMPANY SNAPSHOT (2020) 395
11.1.11 OMRON CORPORATION 401
TABLE 415 OMRON CORPORATION: BUSINESS OVERVIEW 401
FIGURE 50 OMRON CORPORATION: COMPANY SNAPSHOT (2020) 402
11.1.12 KONINKLIJKE PHILIPS N.V. 405
TABLE 416 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 405
FIGURE 51 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 406
11.1.13 GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 412
TABLE 417 GENERAL HEALTHCARE: BUSINESS OVERVIEW 412
FIGURE 52 GENERAL HEALTHCARE SNAPSHOT: COMPANY SNAPSHOT (2020) 413
11.1.14 DRIVE DEVILBISS HEALTHCARE 416
TABLE 418 DRIVE DEVILBISS HEALTHCARE: BUSINESS OVERVIEW 416
11.1.15 HAMILTON MEDICAL 420
TABLE 419 HAMILTON MEDICAL: BUSINESS OVERVIEW 420
11.2 OTHER PLAYERS 422
11.2.1 SUNRISE MEDICAL 422
11.2.2 ROMA MEDICAL 422
11.2.3 CAREMAX REHABILITATION EQUIPMENT CO., LTD. 423
11.2.4 VITALOGRAPH 424
11.2.5 ADVITA PFLEGEDIENST GMBH 424
11.2.6 RENAFAN GMBH 425
11.2.7 ADMR 425
11.2.8 APEX MEDICAL CORP. 426
11.2.9 CONTEC MEDICAL SYSTEMS CO., LTD. 426
11.2.10 LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG. 427
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths/right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 428
12.1 DISCUSSION GUIDE 428
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 434
12.3 AVAILABLE CUSTOMIZATIONS 436
12.4 RELATED REPORTS 437
12.5 AUTHOR DETAILS 438
お問合せフォーム
